无烧素可生物吸收的湿粘合剂的药理动力学和有效性
Risa Oshima1, Kumiko Yoshihara2,3, Ko Nakanishi4
1Department of Periodontology, Faculty of Dental Medicine, Hokkaido University, Sapporo, Japan.
Scientific reports
|June 12, 2025
概括
研究人员从聚糖化合物衍生物脂中开发出无热素的可生物吸收粘合剂. 这项创新为手术密封和药物输送等先进疗法提供了受控的分子量和增强的安全性.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 再生医学是一种再生医学.
背景情况:
- 生物吸收材料对于先进疗法至关重要,但天然选择存在感染风险,而合成材料在内毒素去除方面面临挑战.
- 来自动物的可生物吸收材料,如原蛋白和氨酸,具有良好的生物相容性,但具有感染风险.
- 非动物起源的聚合物通常具有较低的分子量,使粘度控制和内毒素去除复杂化.
研究的目的:
- 开发一种具有可控制分子重量的无素生物可吸收粘合剂.
- 解决现有的天然和合成生物吸收材料的局限性.
- 创建一个安全有效的材料,用于手术密封,细胞治疗和药物输送.
主要方法:
- 使用化处理方法合成聚糖衍生物,一种聚糖衍生物.
- 对大约30万至超过1400万的分子重量进行控制操作.
- 在体外和体内对生物安全的评估,包括细胞细胞和药理动力学.
- 与现有材料相比,对湿组织的粘附和泄漏的评估.
主要成果:
- 实现了无烟素的光和无法检测的内毒素水平.
- 在广泛范围内的可控制的平均分子重量.
- 通过全面的体外和体内试验证实了多糖衍生物的生物安全性.
- 与当前材料相比,它表现出对湿组织的优越粘附性,泄漏率降低.
结论:
- 通过酸方法合成的脂提供了一种安全的,无热素的可生物吸收粘合剂,具有可调节的分子量.
- 这种新型材料具有出色的生物相容性,有效性和减少泄漏,使其适用于先进的治疗应用.
- 该开发代表了生物吸收材料的重大进步,克服了现有选择的关键局限性.
相关概念视频
01:13Local Anesthetics: Pharmacokinetics
1.5K
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
1.5K
01:28Biopharmaceutics and Pharmacokinetics: Overview
4.7K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.7K
01:30Measurement of Bioavailability: Pharmacokinetic Methods
517
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
517
01:20Measurement of Bioavailability: Pharmacodynamic Methods
1.0K
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
1.0K
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
259
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
259